France restores old thyroid drug after complaints over new one

September 15, 2017
The side effects of the new version of Levothyrox that went on sale in March are said to include cramps, headaches, dizziness and hair loss

An old version of a thyroid medication will be reintroduced in France after thousands of the country's three million users complained of serious side effects from a new formula, the government said Friday.

The side effects of the new of Levothyrox that went on sale in March are said to include cramps, headaches, dizziness and .

The government of President Emmanuel Macron, which has been accused of "shameful indifference" over the scandal, said the old version of the would be reintroduced in two weeks.

The German producer of the drug, Merck Serono, said the new version of the treatment was set to be approved in other European countries.

The French drug watchdog Agence Francaise du Medicament had asked Merck to develop the new formula, which is stabler than the old version, in 2012.

Health Minister Agnes Buzyn told France Inter radio that "alternatives, other brands, other drugs" would be available in a month.

"Gradually... patients will be able to choose the drug that suits them the best," she said.

Only one alternative is currently available in France, L-Thyroxine.

As of Monday, more than 9,000 patients had reported undesirable side effects.

Chantal L'Hoir, the head of a support group, told AFP her association was receiving an average of 1,000 complaints a day.

Levothyrox is used to treat underactive thyroids or following surgery for cancer of the organ, which regulates the body's metabolism.

France is the world's leading consumer of Levothyrox and the first country where the new version was introduced.

France was last hit by a major drug scandal in 2010, when it was revealed that the off-label use of a diabetes drug called Mediator for weight loss could cause fatal heart problems.

The legal fallout from that episode is ongoing.

Explore further: Africa gets generic version of most effective HIV drug

Related Stories

Africa gets generic version of most effective HIV drug

June 28, 2017
The generic version of the most advanced drug against HIV has been introduced in Kenya, a first in Africa where more than 25 million have the disease, the NGO Unitaid said Wednesday.

Epilepsy drug behind up to 4,100 'severe birth defects' in France

April 20, 2017
The epilepsy medication valproate is responsible for "severe malformations" in 2,150 to 4,100 children in France since the drug was first marketed in the country in 1967, according to a preliminary study by French health ...

Merck wins approval for long-delayed surgery revival drug

December 15, 2015
Federal health authorities have approved a new drug that helps patients recover from the numbing effects of certain surgical drugs.

France to call for lower drug prices at G7

March 22, 2016
France will announce a campaign to lower the price of new medicines, hoping world powers at the upcoming G7 meeting will put pressure on the pharmaceutical industry, its health minister said Tuesday.

Recommended for you

Health insurer policies may discourage use of non-opioid alternatives for lower back pain

October 5, 2018
Public and private health insurance policies in the U.S. are missing important opportunities to encourage the use of physical therapy, psychological counseling and other non-drug alternatives to opioid medication for treating ...

Opioid overdoses, depression linked

October 3, 2018
The link between mental health disorders and substance abuse is well-documented. Nearly one in 12 adults in the U.S is depressed, and opioid-related deaths are skyrocketing. As these numbers continue to climb, some mental ...

Do price spikes on some generic drugs indicate problems in the market?

October 1, 2018
A new USC study reports that sudden price spikes for some generic drugs—such as the recently reported increases of a decades-old generic heart medication and an antibiotic—are becoming more common.

Reclassification recommendations for drug in 'magic mushrooms'

September 26, 2018
In an evaluation of the safety and abuse research on the drug in hallucinogenic mushrooms, Johns Hopkins researchers suggest that if it clears phase III clinical trials, psilocybin should be re-categorized from a schedule ...

New study finds concurrent use of prescription drugs and dietary supplements could pose health risks

September 25, 2018
A new University of Hertfordshire study found that using certain over-the-counter herbal medicines and dietary supplements alongside prescription drugs could pose serious health risks, especially amongst older adults.

Drug overdose epidemic has been growing exponentially for decades

September 20, 2018
Death rates from drug overdoses in the U.S. have been on an exponential growth curve that began at least 15 years before the mid-1990s surge in opioid prescribing, suggesting that overdose death rates may continue along this ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.